TechsoMed Secures $2.6M in Funding to Advance Real-Time Monitoring System for Thermal Ablation Procedures

VCBeat (WeChat Official Account: vcbeat) learned from foreign media that Israeli medical device company TechsoMed recently announced the completion of a $2.6 million venture capital financing round. The funds will be used to further develop the company’s product—a real-time monitoring system for ultrasound-based thermal ablation procedures—to accelerate its regulatory approval process.

It is reported that this round of financing was led by Johnson & Johnson Innovation - JJDC, with participation from Screen Holdings, AMIT-Technion, NextLeap Ventures, and Axil Capital.

TechsoMed, founded in 2012 and headquartered in Ramat Gan, Tel Aviv, Israel, is dedicated to developing an image analysis system for thermal ablation. This system helps patients and physicians monitor the thermal ablation process in real time, preventing excessive damage to surrounding healthy tissue caused by thermal ablation devices.

Thermal ablation, in layman's terms, refers to the process of externally heating localized human tissues with high temperatures. This non-invasive therapeutic approach can destroy target tissues within a specific range, thereby achieving therapeutic effects. Currently, the market size for thermal ablation therapy reaches billions, and its applications are extensive, including tumor ablation and the treatment of cardiac arrhythmias.

Compared with surgery, thermal ablation enables patients to recover more quickly after treatment, shortens hospital stays, and reduces the risk of potential complications. Monitoring during thermal ablation procedures is essential; physicians must ensure that only the target tissue is destroyed while sparing surrounding healthy tissue, critical organs, and major blood vessels. However, the current market lacks real-time monitoring systems for thermal ablation, leading to a high failure rate in such treatments.

TechsoMed leverages advanced AI and image analysis technologies to integrate its BioTrace system with standard ultrasound equipment, tracking the unique biological signatures of target tissues as they respond to heat during thermal ablation. By analyzing these signatures, the system can simulate the patient’s “thermal effect” 24 hours post-ablation, thereby enhancing surgeons’ control and accuracy during the procedure.

Working Principle of the Real-Time Monitoring System for Thermal Ablation Procedures (Image Source: Official Website)

Currently, TechsoMed is collaborating with Israel's largest hospital, Sheba Medical Center, to develop this system.

Johnson & Johnson Innovation – JJDC is the investment arm of Johnson & Johnson. Established in 1973 and headquartered in New Brunswick, New Jersey, USA, it is a private equity and venture capital firm. The company engages in venture investments across all stages, focusing on traditional healthcare sectors (such as medical devices, diagnostics, consumer health, and pharmaceuticals) as well as emerging areas of medical innovation (including regenerative medicine, oncology, immunology, infectious diseases, and vaccines).

Screen Holdings was established on October 11, 1943, and is headquartered in Kyoto, Japan. The company primarily develops, manufactures, sells, and maintains semiconductor production equipment in China.

NextLeap Ventures is an early-stage venture capital firm based in Israel, primarily investing in Israeli early-stage high-tech startups. The team possesses extensive technical and managerial expertise, with some members having previously worked in Intel’s strategic planning and business development divisions.

Axil Capita is a venture capital firm headquartered in Tokyo, Japan, focusing on early-stage investments in the biopharmaceutical and healthcare sectors.

(Editor: Wang Chan)